Your Cart is Empty

Jarrow Saccharomyces Boulardii + MOS 90 Capsules

Free Shipping Over $99
Free Shipping Does Not Apply to RTD Drinks, Bars or Food Items.

Jarrow Saccharomyces Boulardii + MOS 90 Capsules

Saccharomyces Boulardii+MOS contains a probiotic yeast that survives passage through the stomach acid and delivers it's benefits right to the intestinal tract. This strain helps protecta nd maintain normal intestinal microflora. 

Jarrow Saccharomyces Boulardii + MOS Product Highlights

  • Provides Support to the Intestinal Tract
  • 5 Billion Per Capsule
  • Vegan & Vegetarian Friendly


Take 1 vegetarian capsule 1 or 2 times per day with water. Or take as directed by your qualified healthcare professional. May be taken with food or on an empty stomach. NOTE: For immune-compromised individuals and children, please consult your healthcare professional before using this product.

Jarrow Saccharomyces Boulardii + MOS Supplement Facts

Serving Size: 1 Capsule

Servings Per Container: 90 Capsules

Saccharomyces Boulardii (an S. cerevisiae strain) 5Billion Viable Cells (min)

Bio-MOS 200mg

[derived from S. cerevisiae, source of MOS MannanOligoSaccharides)]

*Minimum of 5 Billion viable cells at the time of consumption under recommended storage conditions and within best used before date. 

*Daily Value Not Established

Other Ingredients: Silicon dioxide and vitamin C(antioxidant). DRCaps capsules consists of hydroxypropylmethylcellulose.


Saccharomyces Boulardii + MOS does not require refrigeration and can be stored at room temperature. Refrigeration will, however, extend the shelf life. Avoid temperatures above 77ºF (25ºC).


Zhou H, Zhang HJ, Guan L, Zhang YN, Li Y, Sun MJ. Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice. Mol Med Rep. 2018;18(6):5652–5662. doi:10.3892/mmr.2018.9612

Garcia Diaz T, Ferriani Branco A, Jacovaci FA, et al. Use of live yeast and mannan-oligosaccharides in grain-based diets for cattle: Ruminal parameters, nutrient digestibility, and inflammatory response. PLoS One. 2018;13(11):e0207127. Published 2018 Nov 14. doi:10.1371/journal.pone.0207127